Breast Cancer Information and Resources

Related Topics for
Breast Cancer

Nurses Notes

OncoPilot

OncoTips

Abramson
Cancer Center

Continuing
Education

Nursing eNews

Cancer Clinical Trials Matching

ONCOLINK ART GALLERY

Cancer Types

Types of Cancer > Breast Cancer > Treatment Options

Treatment Options

Age and comorbidities affect prognosis and treatment options in breast cancer

Aromatase Inhibitor-Related Joint Pain

Cosmetic Outcomes: Breast Reconstruction and Radiation Therapy

Everything You Ever Wanted to Know about Breast Reconstruction

Interview: Dr. Lawrence J. Solin Interprets The Early Breast Cancer Trialists' Collaborative Group's 15 Year Data of Surgery and Radiotherapy for Breast Cancer

OncoLink Meet the Professor: Brian J. Czerniecki, MD, PhD

OncoLink Meet the Professor: Lawrence J. Solin, MD, FACR

OncoType Dx: Predicting Cancer Recurrence

Pennsylvania First Lady Kathy Schweiker Announces Breast and Cervical Cancer Research Grants

Preparing for Breast Surgery: Helpful Facts

Understanding Your Pathology Report: Breast Cancer

Chemotherapy

A Randomized, Double-blind, Phase III Study Evaluating Fixed Dose, Once-Per-Cycle Pegylated Filgrastim (SD/01) vs Daily Filgrastim to Support Chemotherapy for Breast Cancer

A single Dose of Pegylated Filgrastim (SD/01) is as effective as Daily Filgrastim for Hematologic Support of Chemotherapy in Breast Cancer Patients: Results of a Randomized,k Double-Blind, Phase 3 Trial

ASTRO Patient Summary: Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy

BRCA1 mRNA expression in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy

Chemotherapy Before Surgery for Breast Cancer

Cognitive function, fatigue and menopausal symptoms in women following adjuvant chemotherapy for breast cancer: One and two year follow-up of a prospective controlled study

Combination chemotherapy versus single-agent therapy as first and second-line treatments in metastatic breast cancer: A prospective randomized trial

Cross platform comparison of multigene predictors of response to neoadjuvant paclitaxel/FAC chemotherapy in breast cancer generated by cDNA arrays and Affymetrix GeneChips

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy

Emerging science: Prospective validation of gene expression profiling-based prediction of complete pathologic response to neoadjuvant paclitaxel/FAC chemotherapy in breast cancer

Gene expression profiles predict pathologic complete response to preoperative chemotherapy with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

I may need chemotherapy for my breast cancer. Can I still have breast implants?

Increased Risk of Acute Leukemia After Adjuvant Chemotherapy for Breast Cancer: A Population-Based Study

Older women with node positive (N+) breast cancer (BC) get similar benefits from adjuvant chemotherapy (adj) as younger patients (pts): The Cancer and Leukemia Group B (CALGB) experience

Paclitaxel (T) following doxorubicin/cyclophosphamide(AC) as adjuvant chemotherapy for node positive breast cancer: Results from NSABP B-28

Patterns of Recurrence by Sequence of Chemotherapy and Radiotherapy in Early Stage Breast Cancer

Prediction of the therapeutic response to paclitaxel by gene expression profiling in neoadjuvant chemotherapy for breast cancer

Preliminary Analysis of Radiotherapy Data from CALGB 9082: Variability of Treatment Fields for Local/Regional Breast Cancer and the Impact of High Dose Chemotherapy on the Ability to Deliver Radiation Therapy

Preliminary Results of High-Dose Chemotherapy in Primary Breast Cancer Show Equivalency to Intermediate-Dose Treatment; 3 Years of Additional Follow-up Required

Preoperative Chemotherapy for Breast Cancer

Preventing Chemotherapy-associated Amenorrhea (CRA) With Leuprolide In Young Women With Early-stage Breast Cancer

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy

RIBBON-1: Randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC)

Scandinavian Study Finds No Overall Survival Benefit to High-Dose Chemotherapy in Primary Breast Cancer

Sequencing of Chemotherapy and Radiation Therapy for Patients with Early Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

Small French Study Shows Longer Time to Relapse for High-Dose Chemotherapy in Metastatic Breast Cancer

South African Study Finds Survival Benefit to High-Dose Chemotherapy in Primary Breast Cancer

Standard Chemotherapy Shows Increased Toxicity for Elderly with Node-Positive Breast Cancer

Study of High-Dose Chemotherapy in Metastatic Breast Cancer Finds No Survival Benefit

Timing of Radiation and Chemotherapy with Breast Cancer

Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer

Current Clinical Trials for Breast Cancer at
The University of Pennsylvania

A Double-Blind Phase III Trial of Doxorubicin Hydrochloride Liposome and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL888 in Subjects With Solid Tumors

A Phase 1, Open-Label, Non-randomized, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TL32711 in Adults With Refractory Solid Tumors or Lymphoma

A Phase I Study of Hydroxychloroquine in Combination With Temozolomide in Patients With Advanced Solid Tumors

A Phase I Trial of Hydroxychloroquine in Combination With Temsirolimus in Patients With Refractory Solid Tumors

A Phase I Trial of Photodynamic Therapy with HPPH in Patients with Pleural Malignancy

A Phase I/II Study of MGCD265 in Combination With Erlotinib or Docetaxel in Subjects With Advanced Malignancies and in Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)

A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative Chemotherapy in Women With Node Positive Breast Cancer (T1-4, N1-2, M0) at Initial Diagnosis

A Phase II Trial of Bevacizumab and ABI-007 (Abraxane) as Second-Line Therapy in Her-2 Negative, Hormone Receptor Negative Metastatic Breast Cancer

A Randomized Discontinuation Study of Brivanib Alaninate (BMS-582664) Versus Placebo in Subjects With Advanced Tumors

A Randomized Discontinuation Study of XL184 in Subjects With Advanced Solid Tumors

A Randomized Double-blind Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women With Early-Stage HER-2/Neu Overexpressed/Amplified Breast Cancer

A Randomized Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS

Acupuncture and Aromatase Inhibitor-Related Arthralgia

Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor GSK1120212 in Subjects With Solid Tumors or Lymphoma

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

High Dose Granulocyte Transfusions for the Treatment of Infection in Neutropenia: The RING Study (Resolving Infection in Neutropenia With Granulocytes)

I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)

Phase I, Combining Oral Topotecan With Oral Pazopanib

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients With One to Three Cerebral Metastases

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial

Retreatment of Recurrent Tumors Using Proton Therapy

Weight Loss to Prevent BCRL: A Pilot Study

Hormonal Therapy

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

A Phase II Study (GOG 153) of Recurrent and Advanced Endometrial Carcinoma Treated with Alternating Courses of Megestrol Acetate and Tamoxifen Citrate

A Randomized Trial of Tamoxifen With or Without Breast Radiation in Women With Early Breast Cancer 50 Years of Age and Over

Adjuvant ovarian suppression combined with tamoxifen or anastrazole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive, stage I and II breast cancer: First efficacy results from ABCSG

Aromatase inhibitors after Tamoxifen

Aromatase Inhibitors or Tamoxifen

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

ASTRO Patient Summary: Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

Benefit from exemestane (EXE) as extended adjuvant therapy after 5 years of tamoxifen (TAM): intent-to-treat analysis of NSABP B-33

BIG 1-98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for post-menopausal women with receptor-positive breast cancer.

Chemohormonal therapy in premenopausal node-positive, receptor positive breast cancer: An Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT 0101)

Combined Modality Treatment of Locally Advanced Breast Carcinoma in Elderly Patients or Patients with Severe Comorbid Conditions Using Tamoxifen as the Primary Therapy

Comparison Of Lumpectomy Plus Tamoxifen With And Without Radiotherapy (RT) In Women 70 Years Of Age Or Older Who Have Clinical Stage I, Estrogen Receptor Positive (ER+) Breast Carcinoma

Effect Of Raloxifene After Tamoxifen On Breast And Endometrial Cancer Growth

Efficacy of Tamoxifen for Metastatic Breast Cancer

Elevated CA125 Level and Tamoxifen

Estrogen receptor negative breast cancers

First Independent Assessment of Breast Cancer Risk Reduction Drugs Supports a Role for Tamoxifen Therapy

Hair loss in rare patients on tamoxifen

Hot Flashes on Tamoxifen

Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation Treatment

Long-Term Results of a Randomized Trial of Tamoxifen With or Without Radiation in Women Over 50 Years of Age With T1/2 N0 Breast Cancer

Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer: a report of further follow-up

Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer

Medications that Interact with Tamoxifen

Non-Adherence with Adjuvant Tamoxifen Therapy in Women with Early Stage Breast Cancer

Overall Survival After Cyclophosphamide, Adriamycin, 5-FU, And Tamoxifen (CAFT) Is Superior To T Alone In Postmenopausal, Receptor (+), Node (+) Breast Cancer: New Findings From Phase III Southwest Oncology Group Intergroup Trial S8814 (INT-0100)

Patient Summary: The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Preliminary Results Of A Randomized Study Of Tamoxifen +/- Breast Radiation In T1/2 N0 Disease In Women Over 50 Years Of Age

Preliminary Results of a Randomized Study of Tamoxifen Alone or Tamoxifen and Breast Radiation in Women over 50 Years of Age with T1/2 N0 Disease

Prevention Of Breast Cancer With Tamoxifen: Preliminary Findings From The Italian Randomised Trial Among Hysterectomised Women

Radiation and Tamoxifen for DCIS

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Randomized Trial Of 2 Vs. 5 Years Of Adjuvant Tamoxifen In Postmenopausal Women With Early-Stage Breast Cancer

Tamoxifen After Endometrial Cancer

Tamoxifen after Mastectomy

Tamoxifen after total hysterectomy and ovary removal

Tamoxifen Also Effective in Stopping Abnormal Breast Cells from Becoming Cancerous

Tamoxifen and Radiation Therapy for Early Breast Cancer

Tamoxifen and vaginal estrogen use

Tamoxifen and weight gain

Tamoxifen for DCIS

Tamoxifen for Male Breast Cancer

Tamoxifen for weakly positive Estrogen and Progesterone breast cancers

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial

Tamoxifen Reduces Breast Cancer Incidence by 45% in Women at High Risk of Developing the Disease

Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk

Tamoxifen Therapy for Estrogen Receptor Negative Breast Cancer

Tamoxifen Withdrawal

Tamoxifen-induced Cancer?

The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation therapy.

The Role of Radiotherpay and Tamoxifen in the Management of Node Negative Invasive Breast Cancer </= 1.0 cm Treated with Lumpectomy: Preliminary Results of NSABP Protocol B-21

The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study

The use of tamoxifen in patients with DCIS

The Value of Adding Radiation to Tamoxifen in Post-Menopausal Women with Stage I Breast Cancer: A Decision Analysis

Weaning Tamoxifen?

Breast Cancer

Radiation Oncology

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

A Randomized Trial Comparing Two Fractionation Schedules for Breast Irradiation Postlumpectomy in Node-Negative Breast Cancer

A Randomized Trial of Tamoxifen With or Without Breast Radiation in Women With Early Breast Cancer 50 Years of Age and Over

Accelerated Partial Breast Irradiation Via Interstitial Brachytherapy as the Sole Radiation Modality for Treatment of Early-Stage Breast Cancer

Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831

Adjuvant Radiotherapy in Pre-Menopausal Women with Breast Cancer

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

ASTRO Patient Summary: Concurrent Trastuzumab and Radiation Therapy (RT) in the Adjuvant Treatment of Breast Cancer

ASTRO Patient Summary: Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

ASTRO Patient Summary: Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy

Black and White Patients Fare Equally Well When Treated with Post-lumpectomy Radiotherapy

BRCA1/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1/BRCA2 Mutation

Breast Cancer After Supradiaphragmatic Irradiation for Hodgkin's Disease; Risk Analysis and Possible Surveillance Strategies

Breast Cancer Patients Attitudes Towards Clinical Trials in the Radiation Oncology Clinic Versus Those Searching for Trial Information on the Internet

Breast Magnetic Resonance Imaging in the Management of Early Breast Cancer: Implications for Partial Breast Irradiation

Breast reconstruction after lumpectomy and radiation treatment

Chest Wall Radiation Alone for Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated by Mastectomy

Comparison Of Lumpectomy Plus Tamoxifen With And Without Radiotherapy (RT) In Women 70 Years Of Age Or Older Who Have Clinical Stage I, Estrogen Receptor Positive (ER+) Breast Carcinoma

Concurrent Trastuzumab and Radiation Therapy (RT) in the Adjuvant Treatment of Breast Cancer

Consensus Statement on Postmastectomy Radiation Therapy

Conservative breast surgery with radiation vs. mastectomy for Paget's Disease

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Extracapsular Axillary Nodal Extension (ECE) in Breast Cancer: Patterns of Recurrence, Arm Edema, and Survival after Mastectomy with and Without Irradiation

Fatigue During Radiation Therapy of Patients with Breast Cancer

Five year results of Intergroup Study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS)

Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation Treatment

Impact of Postoperative Radiation Therapy on Postmastectomy Breast Reconstruction

Initial Efficacy Results of RTOG 0319: Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I/II Breast Carcinoma

Internal Mammary Node Irradiation Does Not Decrease Distant Metastases or Improve Survival in Stages I and II Breast Cancer

Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy

Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence

Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer

Long-Term Results of a Randomized Trial of Tamoxifen With or Without Radiation in Women Over 50 Years of Age With T1/2 N0 Breast Cancer

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer: a report of further follow-up

Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer

Patient Summary: Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831

Patterns of Recurrence by Sequence of Chemotherapy and Radiotherapy in Early Stage Breast Cancer

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Preliminary Results Of A Randomized Study Of Tamoxifen +/- Breast Radiation In T1/2 N0 Disease In Women Over 50 Years Of Age

Preliminary Results of a Randomized Study of Tamoxifen Alone or Tamoxifen and Breast Radiation in Women over 50 Years of Age with T1/2 N0 Disease

Pulmonary radiological-, physiological-, and clinical side-effects after adjuvant radiotherapy in breast cancer

Radiation after Mastectomy with Reconstruction

Radiation and Tamoxifen for DCIS

Radiation for recurrent breast cancer after prior radiation

Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy

Radiation therapy for breast cancer

Radiation Therapy for Hodgkin's Disease and Breast Cancer

Radiation to the chest after previous radiation for breast cancer

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Results of the Phase III ENRICH (RT-016) Study of Efaproxiral Administered Concurrently with Whole Brain Radiation Therapy (WBRT) in Women with Brain Metastases from Breast Cancer

Results of Whole Brain Radiation Therapy in Breast Cancer Patients with Brain Metastases

Screening Mammography and Radiation Exposure

Second Malignancies after Treatment of Early Stage Breast Cancer with Lumpectomy and Radiation or Mastectomy without Radiation

Second Malignancies after Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy

Sequencing of Chemotherapy and Radiation Therapy for Patients with Early Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

Significance of Axillary Lymph Node Extranodal Soft Tissue Extension and Indications for Postmastectomy Irradiation

Swimming and Exercise While on Radiation Therapy for Breast Cancer?

Tamoxifen and Radiation Therapy for Early Breast Cancer

Ten-Year outcomes for elderly women treated with breast-conserving surgery and definitive breast irradiation for early stage breast cancer.

Ten-year Results of a Randomized Trial of Internal Mammary Chain Irradiation after Mastectomy

The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance"

The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation therapy.

The Impact of Regional Nodal Radiation In Patients With Early-Stage Breast Cancer with Clinically Negative Nodes Treated with Breast-Conserving Therapy

The Value of Adding Radiation to Tamoxifen in Post-Menopausal Women with Stage I Breast Cancer: A Decision Analysis

Timescale of Evolution of Late Radiation Injury after Postoperative Radiotherapy of Breast Cancer Patients

Timing of first mammography after radiation treatment

Timing of Radiation and Chemotherapy with Breast Cancer

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer

Value of adjuvant radiation therapy in breast cancer patients with one to three positive lymph nodes undergoing a modified radical mastectomy and systemic therapy

Surgical Oncology

A Randomized Trial Comparing Two Fractionation Schedules for Breast Irradiation Postlumpectomy in Node-Negative Breast Cancer

Abdominal Exercise after Mastectomy

Are all women candidates for immediate breast reconstruction after breast cancer surgery or treatment?

ASTRO Patient Summary: Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

Black and White Patients Fare Equally Well When Treated with Post-lumpectomy Radiotherapy

Blood draw after mastectomy

Blood pressures, IV's and fingersticks after mastectomy

BRCA1/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1/BRCA2 Mutation

Breast reconstruction after lumpectomy and radiation treatment

Chemotherapy Before Surgery for Breast Cancer

Chest Wall Radiation Alone for Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated by Mastectomy

Comparison Of Lumpectomy Plus Tamoxifen With And Without Radiotherapy (RT) In Women 70 Years Of Age Or Older Who Have Clinical Stage I, Estrogen Receptor Positive (ER+) Breast Carcinoma

Consensus Statement on Postmastectomy Radiation Therapy

Conservative breast surgery with radiation vs. mastectomy for Paget's Disease

Detection of local recurrence after mastectomy and breast reconstruction using a tissue flap

Do I need to have breast reconstruction after my surgery for breast cancer?

Drive Through Mastectomy

Effect of Nancy Reagan's Mastectomy on Choice of Surgery for Breast Cancer by US Women

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

Eighteen-Year Results in the Treatment of Early-Stage Breast Cancer With Breast Conservation Versus Mastectomy

Exercise after mastectomy

Extracapsular Axillary Nodal Extension (ECE) in Breast Cancer: Patterns of Recurrence, Arm Edema, and Survival after Mastectomy with and Without Irradiation

I am interested in breast implant reconstruction after my breast cancer surgery. What is involved?

Impact of Postoperative Radiation Therapy on Postmastectomy Breast Reconstruction

Initial Efficacy Results of RTOG 0319: Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I/II Breast Carcinoma

Is implant removal necessary for breast cancer surgery?

Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy

Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence

Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer

Long-term Satisfaction and Psychological and Social Function Following Bilateral Prophylactic Mastectomy

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer: a report of further follow-up

Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer

Lumpectomy vs. Mastectomy

Mammogram after Mastectomy?

Optimal Timing of Breast Cancer Surgery Within Menstrual Cycle

Prognostic Value of p53 for Local Failure in Mastectomy-Treated Breast Cancer Patients

Prophylactic Mastectomy

Prophylactic Mastectomy Satisfactory to Majority of Patients

Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 Testing

Radiation after Mastectomy with Reconstruction

Reoccurrence in BRCA1 Patients after Lumpectomy

Second Malignancies after Treatment of Early Stage Breast Cancer with Lumpectomy and Radiation or Mastectomy without Radiation

Second Malignancies after Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy

Significance of Axillary Lymph Node Extranodal Soft Tissue Extension and Indications for Postmastectomy Irradiation

Skin Sparing Mastectomy

Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma

Tamoxifen after Mastectomy

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial

Ten-Year outcomes for elderly women treated with breast-conserving surgery and definitive breast irradiation for early stage breast cancer.

Ten-year Results of a Randomized Trial of Internal Mammary Chain Irradiation after Mastectomy

The Role of Radiotherpay and Tamoxifen in the Management of Node Negative Invasive Breast Cancer </= 1.0 cm Treated with Lumpectomy: Preliminary Results of NSABP Protocol B-21

Treatment after lumpectomy in small estrogen negative tumors

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer

Value of adjuvant radiation therapy in breast cancer patients with one to three positive lymph nodes undergoing a modified radical mastectomy and systemic therapy

What are the major types of breast reconstruction available to patients who have had breast cancer surgery?

Why do people choose flap reconstruction after breast cancer surgery?